2nd Quarter - Report

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
—
Expenses
$724,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 933, Continuing Resolution Act of 2013 - Lobbied Members of Congress to: oppose extending Medicaid rebates to Part D; to increase access to HIV/AIDS Drugs in the AIDS Drug Assistance Program; and to prevent importation of prescription drugs. Labor, HHS Appropriations - Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program.Health Care Reform Implementation - Lobbied Members of Congress and the Administration to support open access to pharmaceuticals in the Essential Health Benefits Plan S.959/ H.R. 1919 Supply Chain legislation - Lobbied for passage of legislation to increase security of the drug distribution supply chain. Agriculture Appropriations - Lobbied to shield PDUFA user fees from sequestration from FY14 and beyond S. 539/H.R. 1074 - Lobbied for a public health approach to diabetes prevention and management No bill - Lobbied Members of Congress to raise awareness about Atrial Fibrillation and stroke prevention.

LobbyistCovered position, as disclosed
RONALD MILLER —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Bills named: H.R. 1919 (113th), S. 959 (113th), S. 539 (113th), H.R. 933 (113th), H.R. 1074 (113th)

Medicare/Medicaid MMM

H.R. 1325 and S. 323, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013Lobbied for passage of legislation to remove cap on Medicare reimbursement of immunosuppressive therapy.H.R. 1416, Cancer Patient Protection Act of 2013 - Lobbied Members of Congress to support appropriate reimbursement for Medicare Part B drugs. Legislation to Repeal the Independent Payment Advisory Board - Lobbied for passage of bill to eliminate the Independent Payment Advisory Board

LobbyistCovered position, as disclosed
RONALD MILLER —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Bills named: S. 323 (113th), H.R. 1416 (113th), H.R. 1325 (113th)

Budget/Appropriations BUD

S.CON.RES.8 and H. Con. Res 25 - Lobbied Members of Congress to oppose: extending Medicaid rebates to Part D; allowing for the importation of pharmaceuticals; and banning patent settlements between brand and generic drug manufacturers.

LobbyistCovered position, as disclosed
RONALD MILLER —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); State, Dept of (DOS)

Bills named: S.Con.Res. 8 (113th), H.Con.Res. 25 (113th)

Trade (domestic/foreign) TRD

No Bill, Trade and international IP issues.Lobbied to strengthen intellectual property rights in trade agreements and international negotiations.

LobbyistCovered position, as disclosed
RONALD MILLER —
LANE PENRY —
CHRISTOPHER PERNIE —
PAUL ANTHONY WILLIAMS New —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.